Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Laughlin

Showing results (111-120 of 125) with videos related to

Pageof 13
Sort By:
American Journal of Obstetrics and Gynecology|November 4, 2019
Short-term quality of life after myomectomy for uterine fibroids from the COMPARE-UF Fibroid RegistryShannon K Laughlin-Tommaso, Di Lu, Laine Thomas, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2005
The development of new isoxazolone based inhibitors of tumor necrosis factor-alpha (TNF-alpha) productionSteven K Laughlin, Michael P Clark, Jane F Djung, et al.
Obstetrics and Gynecology|February 27, 2025
Diagnostic Algorithms for Adnexal Masses in the Hands of a Novice OperatorLuigi A De Vitis, Gabriella Schivardi, Leah Grcevich, et al.
Fertility and Sterility|March 21, 2020
Comparative effectiveness of hysterectomy versus myomectomy on one-year health-related quality of life in women with uterine fibroidsKedra Wallace, Shuaiqi Zhang, Laine Thomas, et al.
Implementation Science : IS|November 6, 2024
The UPFRONT project: tailored implementation and evaluation of a patient decision aid to support shared decision-making about management of symptomatic uterine fibroidsRachel C Forcino, Marie-Anne Durand, Danielle Schubbe, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
The development of novel inhibitors of tumor necrosis factor-alpha (TNF-alpha) production based on substituted [5,5]-bicyclic pyrazolonesMatthew J Laufersweiler, Todd A Brugel, Michael P Clark, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2005
The development of monocyclic pyrazolone based cytokine synthesis inhibitorsAdam Golebiowski, Jennifer A Townes, Matthew J Laufersweiler, et al.
American Journal of Obstetrics and Gynecology|April 14, 2016
Fibroid interventions: reducing symptoms today and tomorrow: extending generalizability by using a comprehensive cohort design with a randomized controlled trialAhmed M AbdElmagied, Lisa E Vaughan, Amy L Weaver, et al.
American Journal of Obstetrics and Gynecology|January 14, 2026
Fibroids and Health Disparities: The COllaboration for EQuity in Uterine Leiomyomas (COEQUaL) Specialized CenterElizabeth A Stewart, Sateria Venable, Bijan J Borah, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2006
Development of new pyrrolopyrimidine-based inhibitors of Janus kinase 3 (JAK3)Michael P Clark, Kelly M George, Roger G Bookland, et al.
Pageof 13

Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
American Journal of Obstetrics and Gynecology|November 4, 2019
Short-term quality of life after myomectomy for uterine fibroids from the COMPARE-UF Fibroid RegistryShannon K Laughlin-Tommaso, Di Lu, Laine Thomas, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2005
The development of new isoxazolone based inhibitors of tumor necrosis factor-alpha (TNF-alpha) productionSteven K Laughlin, Michael P Clark, Jane F Djung, et al.
Obstetrics and Gynecology|February 27, 2025
Diagnostic Algorithms for Adnexal Masses in the Hands of a Novice OperatorLuigi A De Vitis, Gabriella Schivardi, Leah Grcevich, et al.
Fertility and Sterility|March 21, 2020
Comparative effectiveness of hysterectomy versus myomectomy on one-year health-related quality of life in women with uterine fibroidsKedra Wallace, Shuaiqi Zhang, Laine Thomas, et al.
Implementation Science : IS|November 6, 2024
The UPFRONT project: tailored implementation and evaluation of a patient decision aid to support shared decision-making about management of symptomatic uterine fibroidsRachel C Forcino, Marie-Anne Durand, Danielle Schubbe, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
The development of novel inhibitors of tumor necrosis factor-alpha (TNF-alpha) production based on substituted [5,5]-bicyclic pyrazolonesMatthew J Laufersweiler, Todd A Brugel, Michael P Clark, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2005
The development of monocyclic pyrazolone based cytokine synthesis inhibitorsAdam Golebiowski, Jennifer A Townes, Matthew J Laufersweiler, et al.
American Journal of Obstetrics and Gynecology|April 14, 2016
Fibroid interventions: reducing symptoms today and tomorrow: extending generalizability by using a comprehensive cohort design with a randomized controlled trialAhmed M AbdElmagied, Lisa E Vaughan, Amy L Weaver, et al.
American Journal of Obstetrics and Gynecology|January 14, 2026
Fibroids and Health Disparities: The COllaboration for EQuity in Uterine Leiomyomas (COEQUaL) Specialized CenterElizabeth A Stewart, Sateria Venable, Bijan J Borah, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2006
Development of new pyrrolopyrimidine-based inhibitors of Janus kinase 3 (JAK3)Michael P Clark, Kelly M George, Roger G Bookland, et al.
Pageof 13